UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral

Journal of medical genetics, 2006-04, Vol.43 (4), p.295-305

2006

Volltextzugriff (PDF)

Analysis of missense variation in human BRCA1 in the context of interspecific sequence variation

Journal of medical genetics, 2004-07, Vol.41 (7), p.492-507

2004

Volltextzugriff (PDF)

Frequency of germline and somatic BRCA1 mutations in ovarian cancer

Clinical cancer research, 1998-10, Vol.4 (10), p.2433-2437

1998

Volltextzugriff (PDF)

Integrated Evaluation of DNA Sequence Variants of Unknown Clinical Significance: Application to BRCA1 and BRCA2

American journal of human genetics, 2004-10, Vol.75 (4), p.535-544

2004

Volltextzugriff (PDF)

Phenotypic expression of double heterozygosity for BRCA1 and BRCA2 germline mutations

Journal of medical genetics, 2005-03, Vol.42 (3), p.e20-e20

2005

Volltextzugriff (PDF)

A Systematic Genetic Assessment of 1,433 Sequence Variants of Unknown Clinical Significance in the BRCA1 and BRCA2 Breast Cancer–Predisposition Genes

American journal of human genetics, 2007-11, Vol.81 (5), p.873-883

2007

Volltextzugriff (PDF)

Hereditary susceptibility to breast cancer : Significance of age of onset in family history and contribution of BRCA1 and BRCA2

Disease markers, 1999, Vol.15 (1-3), p.89-92

1999

Volltextzugriff (PDF)

Identification of germline 185delAG BRCA1 mutations in non‐Jewish Americans of Spanish ancestry from the San Luis Valley, Colorado

Cancer, 2003-08, Vol.98 (3), p.597-602

2003

Volltextzugriff (PDF)

Single nucleotide polymorphisms in clinical genetic testing: the characterization of the clinical significance of genetic variants and their application in clinical research for BRCA1

Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis, 2005-06, Vol.573 (1), p.168-179

2005

Volltextzugriff (PDF)

Clinical Characteristics of Individuals With Germline Mutations in BRCA1 and BRCA2: Analysis of 10,000 Individuals

Journal of clinical oncology, 2002-03, Vol.20 (6), p.1480-1490

Frank, T. S.

2002

Volltextzugriff (PDF)

Genetic and histopathologic evaluation of BRCA1 and BRCA2 DNA sequence variants of unknown clinical significance

Cancer research (Chicago, Ill.), 2006-02, Vol.66 (4), p.2019-2027

2006

Volltextzugriff (PDF)

Application of embryonic lethal or other obvious phenotypes to characterize the clinical significance of genetic variants found in trans with known deleterious mutations

Cancer research (Chicago, Ill.), 2005-11, Vol.65 (21), p.10096-10103

2005

Volltextzugriff (PDF)

Molecular genetic testing for large genomic deletion and duplication mutations in the BRCA1 and BRCA2 genes for hereditary breast and ovarian cancer

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.10513-10513

2007

Volltextzugriff (PDF)

The predictive value of BRCA1 and BRCA2 mutation testing

Genetic testing, 2000, Vol.4 (1), p.45-48

2000

Volltextzugriff (PDF)

Recurrent intragenic rearrangement mutations in the tumor suppressor gene BRCA1 : Prevalence results from 12,272 patients at high risk for breast and/or ovarian cancers and methods of biochemical analysis

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.9533-9533

2004

Volltextzugriff (PDF)

Recurrent intragenic rearrangement mutations in the tumor suppressor gene BRCA1 : Prevalence results from 12,272 patients at high risk for breast and/or ovarian cancers and methods of biochemical analysis

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.9533-9533

2004

Volltextzugriff (PDF)

BRCA1/2 Genetic Testing in the Community Setting

Journal of clinical oncology, 2002-11, Vol.20 (22), p.4485-4492

2002

Volltextzugriff (PDF)

Characterization of common BRCA1 and BRCA2 variants

Genetic testing, 2002, Vol.6 (2), p.119-121

2002

Volltextzugriff (PDF)

BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast‐ovarian cancer

Cancer, 2009-05, Vol.115 (10), p.2222-2233

2009

Volltextzugriff (PDF)

Fabrication and Microwave Characterization of 3-D Printed Transmission Lines

IEEE microwave and wireless components letters, 2015-12, Vol.25 (12), p.823-825

2015

Volltextzugriff (PDF)

A 2.45 GHz Phased Array Antenna Unit Cell Fabricated Using 3-D Multi-Layer Direct Digital Manufacturing

IEEE transactions on microwave theory and techniques, 2015-12, Vol.63 (12), p.4382-4394

2015

Volltextzugriff (PDF)

Characterization and Modeling of K-Band Coplanar Waveguides Digitally Manufactured Using Pulsed Picosecond Laser Machining of Thick-Film Conductive Paste

IEEE transactions on microwave theory and techniques, 2017-09, Vol.65 (9), p.3180-3187

2017

Volltextzugriff (PDF)

Integrated genomic DNA/RNA profiling of hematologic malignancies in the clinical setting

Blood, 2016-06, Vol.127 (24), p.3004-3014

2016

Volltextzugriff (PDF)

Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial

Journal of clinical oncology, 2015-07, Vol.33 (20), p.2279-2287

2015

Volltextzugriff (PDF)

Shared Genetic Susceptibility to Breast Cancer, Brain Tumors, and Fanconi Anemia

JNCI : Journal of the National Cancer Institute, 2003-10, Vol.95 (20), p.1548-1551

2003

Volltextzugriff (PDF)

1 – 25 von 75

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(63)
Mit Volltextzugriff
(64)

Publikationsform

Artikel
(68)
Tagungsberichte
(7)

Sprache

Englisch
(75)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral

Analysis of missense variation in human BRCA1 in the context of interspecific sequence variation

Frequency of germline and somatic BRCA1 mutations in ovarian cancer

Integrated Evaluation of DNA Sequence Variants of Unknown Clinical Significance: Application to BRCA1 and BRCA2

Phenotypic expression of double heterozygosity for BRCA1 and BRCA2 germline mutations

A Systematic Genetic Assessment of 1,433 Sequence Variants of Unknown Clinical Significance in the BRCA1 and BRCA2 Breast Cancer–Predisposition Genes

Hereditary susceptibility to breast cancer : Significance of age of onset in family history and contribution of BRCA1 and BRCA2

Identification of germline 185delAG BRCA1 mutations in non‐Jewish Americans of Spanish ancestry from the San Luis Valley, Colorado

Single nucleotide polymorphisms in clinical genetic testing: the characterization of the clinical significance of genetic variants and their application in clinical research for BRCA1

Clinical Characteristics of Individuals With Germline Mutations in BRCA1 and BRCA2: Analysis of 10,000 Individuals

Genetic and histopathologic evaluation of BRCA1 and BRCA2 DNA sequence variants of unknown clinical significance

Application of embryonic lethal or other obvious phenotypes to characterize the clinical significance of genetic variants found in trans with known deleterious mutations

Molecular genetic testing for large genomic deletion and duplication mutations in the BRCA1 and BRCA2 genes for hereditary breast and ovarian cancer

The predictive value of BRCA1 and BRCA2 mutation testing

Recurrent intragenic rearrangement mutations in the tumor suppressor gene BRCA1 : Prevalence results from 12,272 patients at high risk for breast and/or ovarian cancers and methods of biochemical analysis

Recurrent intragenic rearrangement mutations in the tumor suppressor gene BRCA1 : Prevalence results from 12,272 patients at high risk for breast and/or ovarian cancers and methods of biochemical analysis

BRCA1/2 Genetic Testing in the Community Setting

Characterization of common BRCA1 and BRCA2 variants

BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast‐ovarian cancer

Fabrication and Microwave Characterization of 3-D Printed Transmission Lines

A 2.45 GHz Phased Array Antenna Unit Cell Fabricated Using 3-D Multi-Layer Direct Digital Manufacturing

Characterization and Modeling of K-Band Coplanar Waveguides Digitally Manufactured Using Pulsed Picosecond Laser Machining of Thick-Film Conductive Paste

Integrated genomic DNA/RNA profiling of hematologic malignancies in the clinical setting

Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial

Shared Genetic Susceptibility to Breast Cancer, Brain Tumors, and Fanconi Anemia

Suchergebnisse filtern